Hofseth Biocare ASA: CORRECTION: Second Quarter 2019 Financial Report

Reference is made to the stock exchange notice issued on 30 August 2019 regarding the Second Quarter 2019 Financial Report.The section “Declaration by the Board of Directors and CEO” is missing from the issued version. The financial report with the declaration included is attached this notice. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Q2 2019 Financial Report

Reference is made to the stock exchange notice issued on 30 August 2019 regarding the Second Quarter 2019 Financial Report.

The section “Declaration by the Board of Directors and CEO” is missing from the issued version.

The financial report with the declaration included is attached this notice.

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Attachment

• Q2 2019 Financial Report